<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> defined by the presence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> in the esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>Estimates of the incidence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> developing in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> vary widely </plain></SENT>
<SENT sid="2" pm="."><plain>We prospectively followed a cohort of patients to define the incidence </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Between January 1982 and April 1995, <z:hpo ids='HP_0000001'>all</z:hpo> patients undergoing upper endoscopy at the VA Medical Center in Tucson, AZ, were surveyed for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>One hundred seventy-seven patients (174 males, three females) were found to have <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Seven of 177 were found to have <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> either at initial endoscopy or within 6 months, resulting in a prevalence of 4% </plain></SENT>
<SENT sid="6" pm="."><plain>One hundred seventy of 177 patients initially lacking <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were available for systematic survey </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The mean age at the time of Barrett's diagnosis was 62 yr (range 30-85 yr) </plain></SENT>
<SENT sid="8" pm="."><plain>The mean follow-up period was 57 months or 4.8 yr (range 6-156 months), for a total of 834 patient-years </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> developed in four patients, an incidence of 1/208 patient-years of follow-up </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The current series is larger and has a longer follow-up period than previous prospective trials and demonstrates a lower incidence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Surveillance of patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> remains an appropriate clinical practice </plain></SENT>
</text></document>